PHARMAESSENTIA CORPPHARMAESSENTIA CORPPHARMAESSENTIA CORP

PHARMAESSENTIA CORP

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.77TWD
Revenue estimate
‪1.78 B‬TWD
Market capitalization
‪96.21 B‬TWD
‪−623.84 M‬TWD
‪5.11 B‬TWD
‪283.31 M‬
Beta (1Y)
0.39

About PHARMAESSENTIA CORP

CEO
Kuo Chung Lin
Headquarters
Taipei
Founded
2000
FIGI
BBG0063GF1Z0
PharmaEssentia Corp. engages in the research, development, production and sale of drugs. Its business activities include the manufacture and sale of therapeutic products for the treatment of human diseases. The company was founded by Kuo Chung Lin on May 9, 2000 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 6446 is 285.5 TWD — it has decreased by 1.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange PHARMAESSENTIA CORP stocks are traded under the ticker 6446.
PHARMAESSENTIA CORP is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
6446 stock is 2.10% volatile and has beta coefficient of 0.39. Check out the list of the most volatile stocks — is PHARMAESSENTIA CORP there?
6446 earnings for the last quarter are 0.67 TWD per share, whereas the estimation was 0.16 TWD resulting in a 315.72% surprise. The estimated earnings for the next quarter are −1.27 TWD per share. See more details about PHARMAESSENTIA CORP earnings.
PHARMAESSENTIA CORP revenue for the last quarter amounts to ‪1.31 B‬ TWD despite the estimated figure of ‪1.31 B‬ TWD. In the next quarter revenue is expected to reach ‪1.65 B‬ TWD.
Yes, you can track PHARMAESSENTIA CORP financials in yearly and quarterly reports right on TradingView.
6446 stock has fallen by 5.78% compared to the previous week, the month change is a 10.50% fall, over the last year PHARMAESSENTIA CORP has showed a 11.47% decrease.
6446 net income for the last quarter is ‪115.94 M‬ TWD, while the quarter before that showed ‪198.52 M‬ TWD of net income which accounts for −41.60% change. Track more PHARMAESSENTIA CORP financial stats to get the full picture.
Today PHARMAESSENTIA CORP has the market capitalization of ‪94.76 B‬, it has decreased by 5.11% over the last week.
No, 6446 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6446 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMAESSENTIA CORP stock right from TradingView charts — choose your broker and connect to your account.
6446 reached its all-time high on Mar 19, 2024 with the price of 336.0 TWD, and its all-time low was 281.0 TWD and was reached on Apr 19, 2024.
See other stocks reaching their highest and lowest prices.
We've gathered analysts' opinions on PHARMAESSENTIA CORP future price: according to them, 6446 price has a max estimate of 480.00 TWD and a min estimate of 385.00 TWD. Read a more detailed PHARMAESSENTIA CORP forecast: see what analysts think of PHARMAESSENTIA CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMAESSENTIA CORP EBITDA is ‪−1.64 B‬ TWD, and current EBITDA margin is −32.21%. See more stats in PHARMAESSENTIA CORP financial statements.